Detrusor overactivity, neurologic conditions
Also known as: Neurogenic Detrusor Overactivity / Neurogenic detrusor overactivity (disorder) / Detrusor hyperreflexia
Drug | Drug Name | Drug Description |
---|---|---|
DB00083 | Botulinum toxin type A | A purified form of botulinum toxin type A used to block acetylcholine release in the treatment of chronic sialorrhea, muscle spasticity, and dystonia, as well as in cosmetic applications. |
DB06702 | Fesoterodine | An antimuscarinic agent used in the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. |
DB08893 | Mirabegron | A beta-3 adrenergic agonist used to treat overactive bladder and neurogenic detrusor overactivity. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB06702 | Fesoterodine | 1 | Completed | 2 |
DB08893 | Mirabegron | 1 | Completed | 2 |
DB01591 | Solifenacin | 1 | Completed | 1 |
DB00209 | Trospium | 1 | Completed | 1 |
DB00496 | Darifenacin | 2 | Terminated | 1 |
DB06702 | Fesoterodine | 2 | Completed | 1 |
DB14895 | Vibegron | 2 / 3 | Recruiting | 1 |
DB00083 | Botulinum toxin type A | 3 | Completed | 1 |
DB08893 | Mirabegron | 3 | Completed | 1 |
DB08893 | Mirabegron | 3 | Recruiting | 1 |
DB01591 | Solifenacin | 3 | Completed | 2 |
DB00496 | Darifenacin | 4 | Completed | 1 |
DB01062 | Oxybutynin | 4 | Completed | 1 |
DB00209 | Trospium | 4 | Completed | 1 |